NCT04274153View on ClinicalTrials.gov

HPV Vaccination Study in Postpartum Women

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

February 1, 2023

Conditions
HPVImmunizationHuman Papilloma Virus
Interventions
BIOLOGICAL

Gardasil9

Two doses of the HPV vaccine across a 12 month period (two doses of 0.5mL).

Trial Locations (2)

21205

Johns Hopkins University, Baltimore

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04274153 - HPV Vaccination Study in Postpartum Women | Biotech Hunter | Biotech Hunter